Concepedia
Statistics
Publications
14
Citations
292
H-Index
12
Active since
2009
Affiliations
Capital Medical University(Current)
Beijing Friendship Hospital
Capital University
Yuting Liu is an author at Capital Medical University specializing in medicine, oncology, and cancer cell signaling.
Publications per year
2009–2023
TGFBI-promoted Adhesion, Migration and Invasion of Human Renal Cell Carcinoma Depends on Inactivation of von Hippel-Lindau Tumor Suppressor
Donghao Shang, Yuting Liu, Peiqian Yang et al. · Urology · 2012 · 55 citations
Medicine, Cell Biology, Oncology +12
Rolipram promotes remyelination possibly via MEK-ERK signal pathway in cuprizone-induced demyelination mouse
Xiaojia Sun, Yuting Liu, Boyang Liu et al. · Experimental Neurology · 2012 · 47 citations
Life Sciences, Neurology, Neuroscience +14
Synergy of 5-aza-2′-deoxycytidine (DAC) and paclitaxel in both androgen-dependent and -independent prostate cancer cell lines
Donghao Shang, Yuting Liu, Qingjun Liu et al. · Cancer Letters · 2009 · 27 citations
Medicine, Oncology, Pharmacology +12
5-Aza-2′-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression
Donghao Shang, Yuting Liu, Xiuhong Xu et al. · Cancer Letters · 2011 · 22 citations
Medicine, Cancer Biology, Oncology +13
Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
Donghao Shang, Tiandong Han, Xiuhong Xu et al. · PubMed · 2015 · 18 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 14